Aurisco PharmaceuticalLtd's sound financials and higher than average ROE could make it an attractive investment despite recent stock decline. Its decent net income growth and efficient reinvestment of earnings add to its appeal.

Despite solid growth, the company's high P/E ratio is worrisome. Investors' bullishness may not last as earnings growth could impact share price. High share price and future earnings predictions may not sustain positivity, risking shareholders' investments and potential investors paying a premium.